Current Problems in Cardiology
Volume 34, Issue 4 , Pages 145-217 , April 2009

Coronary Computed Tomography and Magnetic Resonance Imaging

References 

  1. Libby P. Inflammation in atherosclerosis. Nature. 2002;6917:868–874
  2. Blackshear JL, Kantor B. Pathogenesis of atherosclerosis. In:  Murphy JG editors. Mayo Clinic Cardiology Concise Textbook. 3rd edition. London, New York: Lippincott Williamson and Wilkins; 2006;p. 699–715
  3. Virmani R, Burke A, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;8(suppl):C13–C18
  4. Jaffer F, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol. 2006;7:1328–1338
  5. Kantor B, Jorgensen S, Lund P, et al. Cryostatic micro-CT imaging of arterial wall perfusion. Scanning. 2002;24:186–190
  6. Stary H. Natural history and histological classification of atherosclerotic lesions: An update. Arterioscler Thromb Vasc Biol. 2000;20:1177–1178
  7. Miller D. Pathology of coronary artery atherosclerosis: aspects relevant to cardiac imaging. In:  Gerber T,  Kantor B,  Williamson E editor. Computed Tomography for the Cardiovascular System. London, UK: Informa Healthcare; 2008;
  8. Ross R. Atherosclerosis—An inflammatory disease. N Engl J Med. 1999;2:115–126
  9. Bjoernheden T, Evaldsson M, Wiklund O. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arterioscler Thromb Vasc Biol. 1996;16:178–185
  10. Kantor B, Moehlenkamp S. Imaging the myocardial microvasculature using fast computed tomography and three-dimensional microscopic computed tomography. Cardiol Clin. 2003;21:587–605
  11. Moreno P, Purushothaman K, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004;110:2032–2038
  12. Langheinrich AC, Kampschulte M, Buch T, et al. Vasa vasorum and atherosclerosis—Quid Novi?. Thromb Haemost. 2007;97:873–879
  13. Kolodgie F, Gold H, Burke A, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316–2325
  14. Virmani R, Kolodgie F, Burke A. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;10:2054–2061
  15. Winter P, Caruthers SW, Wickline SA, et al. Molecular imaging by MRI. Curr Cardiol Rep. 2006;1:65–69
  16. Winter P, Shukla H, Caruthers S, et al. Molecular imaging of human thrombus with computed tomography. Acad Radiol. 2005;12(suppl 1):S9–S13
  17. Giachelli C, Bae N, Almeida M, et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;4:1686–1696
  18. Mautner G, Mautner S, Froehlich J, et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology. 1994;3:619–623
  19. Schoenhagen P, Nissen SE, Tuzcu EM. Coronary arterial remodeling: from bench to bedside. Curr Atheroscler Rep. 2003;2:150–154
  20. Glagov S, Weisenberg E, Zarins C, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;22:1371–1375
  21. Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944–1951
  22. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994;330:1782–1788
  23. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee to Update the 1997 exercise testing guidelines). Circulation. 2002;106:1883–1892
  24. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol. 1995;26:450–456
  25. Fleiner M, Kummer M, Mirlacher M. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004;18:2843-250
  26. Langheinrich AC, Michniewicz A, Sedding DG, et al. Correlation of Vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(−/−)/low-density lipoprotein(−/−) double knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:347–352
  27. Zbinden S, Clavijo L, Kantor B, et al. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol. 2007;4:H1891–H1897
  28. Hyafil F, Cornily JC, Feig JE, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007;13:636–641
  29. Winter P, Morawski A, Caruthers S. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003;108:2270–2274
  30. Anderson S, Rader R, Westlin W, et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med. 2000;3:433–439
  31. Fayad Z, Sirol M, Nikolaou K, Choudhury R, Fuster V. Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque. Curr Atheroscler Rep. 2004;6:232–242
  32. Jaffer F, Tung C, Gerszten R, Weissleder R. In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol. 2002;22:1929–1935
  33. Kolodgie F, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation. 2003;108:3134–3139
  34. Gerber T, Kantor B, Williamson E. Computed Tomography of the Cardiovascular System. London: Informa Healthcare; 2008;
  35. Lardo AC, Fayad Z, Chronos N. Cardiovascular Magnetic Resonance: Established and Emerging Applications. London: Informa Healthcare; 2004;
  36. Boyd DP, Lipton MJ. Cardiac computed tomography. Proc IEEE. 1983;71:298–307
  37. Ohnesorge B, Flohr T, Becker C, et al. Cardiac imaging by means of electrocardiographically gated multisection spiral CT: initial experience. Radiology. 2000;217:564–571
  38. Flohr TG, McCollough CH, Bruder H, et al. First performance evaluation of a dual-source CT (DSCT) system. Eur Radiol. 2006;16:256–268
  39. Achenbach S, Ropers D, Kuettner A, et al. Contrast-enhanced coronary artery visualization by dual-source computed tomography—initial experience. Eur J Radiol. 2006;57:331–335
  40. Gerber T, Walser E. Cardiovascular computed tomography and magnetic resonance imaging. In:  Murphy JL editors. Mayo Clinic Cardiology Concise Textbook. London, New York: Williamson, Lippincott and Wilkins; 2006;p. 185–204
  41. al Agatston ASE. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832
  42. Callister TQ, Cooil B, Raya SP, et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology. 1998;208:807–814
  43. Ulzheimer S, Kalender WA. Assessment of calcium scoring performance in cardiac computed tomography. Eur Radiol. 2003;13:484–497
  44. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications (A statement for health professionals from the American Heart Association Writing Group). Circulation. 1996;94:1175–1192
  45. Hoff JA, Chomka EV, Krainik AJ, et al. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol. 2001;87:1335–1339
  46. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–855
  47. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49:378–402
  48. Gerber TC, Kuzo RS, Lane GE, et al. Image quality in a standardized algorithm for minimally invasive coronary angiography with multislice spiral computed tomography. J Comput Assist Tomogr. 2003;27:62–69
  49. Gerber TC, Breen JF, Kuzo RS, et al. Computed tomographic angiography of the coronary arteries: techniques and applications. Semin Ultrasound CT MR. 2006;27:42–55
  50. Lawler LP, Pannu HK, Fishman EK. MDCT evaluation of the coronary arteries, 2004: how we do it—data acquisition, postprocessing, display, and interpretation. AJR Am J Roentgenol. 2005;184:1402–1412
  51. van Ooijen PM, Ho KY, Dorgelo J, et al. Coronary artery imaging with multidetector CT: visualization issues. Radiographics. 2003;23:e16
  52. McCollough CH, Schueler BA. Calculation of effective dose. Med Phys. 2000;27:828–837
  53. Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures. J Nucl Cardiol. 2006;13:19–23
  54. Amis ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007;4:272–284
  55. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298:317–323
  56. (BEIR) CotBEoIR. In: Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase. vol. 2:Washington, DC: The National Academies; 2005;
  57. Bucciarelli-Ducci C, Wu E, Lee DC, et al. Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease. Curr Probl Cardiol. 2006;31:128–168
  58. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation. 2006;114:1232–1233
  59. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116:2878–2891
  60. Gerber TC, Fasseas P, Lennon RJ, et al. Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol. 2003;42:1295–1298
  61. Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647–649
  62. United States Food and Drug Administration (FDA). Information on gadolinium-containing contrast agents. 2008;
  63. Wolff SD, Schwitter J, Coulden R, et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation. 2004;110:732–737
  64. Gebker R, Schwitter J, Fleck E, Nagel E. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9:539–547
  65. Klocke FJ, Simonetti OP, Judd RM, et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation. 2001;104:2412–2416
  66. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–1638
  67. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–542
  68. Elkington AG, Gatehouse PD, Prasad SK, et al. Combined long- and short-axis myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2004;6:811–816
  69. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432–437
  70. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004;110:835–842
  71. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson. 2001;3:267–281
  72. Cerqueira M, Verani M, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:390–392
  73. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J. 2004;25:1230–1236
  74. van Geuns R, Wielopolski P, Wardeh A, et al. Volume coronary angiography using targeted scans (VCATS): a new strategy in MR coronary angiography. Int J Cardiovasc Imaging. 2001;17:405–410
  75. Jahnke C, Paetsch I, Achenbach S, et al. Coronary MR imaging: breath-hold capability and patterns, coronary artery rest periods, and beta-blocker use. Radiology. 2006;239:71–78
  76. Stuber M, Botnar R, Danias P, et al. Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol. 1999;34:524–531
  77. Weber O, Martin A, Higgins C. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med. 2003;50:1223–1228
  78. Brittain JH, Hu BS, Wright GA, et al. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med. 1995;33:689–696
  79. Barkhausen J, Hunold P, Jochims M, et al. Comparison of gradient-echo and steady state free precession sequences for 3D-navigator MR angiography of coronary arteries. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2002;174:725–730
  80. Nassenstein K, Waltering KU, Eggebrecht H, et al. MR coronary angiography with MS-325, a blood pool contrast agent: comparison of an inversion recovery steady-state free precession with an inversion recovery fast low angle shot sequence in volunteers. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2006;178:508–514
  81. Dirksen MS, Lamb HJ, Kunz P, et al. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs. Radiology. 2003;227:802–808
  82. Paetsch I, Jahnke C, Barkhausen J, et al. Detection of coronary stenoses with contrast enhanced, three-dimensional free breathing coronary MR angiography using the gadolinium-based intravascular contrast agent gadocoletic acid (B-22956). J Cardiovasc Magn Reson. 2006;8:509–516
  83. Herborn CU, Barkhausen J, Paetsch I, et al. Coronary arteries: contrast-enhanced MR imaging with SH L 643 A—experience in 12 volunteers. Radiology. 2003;229:217–223
  84. Herborn CU, Schmidt M, Bruder O, et al. MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease. Radiology. 2004;233:567–573
  85. Jahnke C, Dietrich T, Paetsch I, et al. Experimental evaluation of the detectability of submillimeter atherosclerotic lesions in ex vivo human iliac arteries with ultrahigh-field (7.0 T) magnetic resonance imaging. Int J Cardiovasc Imaging. 2007;23:519–527
  86. Barkhausen J, Ebert W, Heyer C, et al. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation. 2003;108:605–609
  87. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415–422
  88. Wickline SA, Neubauer AM, Winter PM, et al. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J Magn Reson Imaging. 2007;25:667–680
  89. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001;104:1280–1285
  90. Morawski AM, Winter PM, Crowder KC, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med. 2004;51:480–486
  91. Janowitz WR, Agatston AS, Kaplan G, et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol. 1993;72:247–254
  92. Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation. 2002;105:1791–1796
  93. Haberl R, Becker A, Leber A, et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol. 2001;37:451–457
  94. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area (A histopathologic correlative study). Circulation. 1995;92:2157–2162
  95. Simons DB, Schwartz RS, Edwards WD, et al. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992;20:1118–1126
  96. Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol. 2004;44:923–930
  97. Knez A, Becker A, Leber A, et al. Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2,115 symptomatic patients. Am J Cardiol. 2004;93:1150–1152
  98. Laudon DA, Vukov LF, Breen JF, et al. Use of electron-beam computed tomography in the evaluation of chest pain patients in the emergency department. Ann Emerg Med. 1999;33:15–21
  99. Lee RT, Grodzinsky AJ, Frank EH, et al. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation. 1991;83:1764–1770
  100. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions (A structural analysis with histopathological correlation). Circulation. 1993;87:1179–1187
  101. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty (An observational study using intravascular ultrasound). Circulation. 1992;86:64–70
  102. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682–1687
  103. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126–140
  104. Pletcher MJ, Tice JA, Pignone M, et al. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and metal-analysis. Arch Intern Med. 2004;164:1285–1292
  105. Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis heart study. J Am Coll Cardiol. 2005;46:158–165
  106. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–215
  107. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation. 2003;107:2571–2576
  108. LaMonte MJ, FitzGerald SJ, Church TS, et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol. 2005;162:421–429
  109. Taylor AJ, Bindeman J, Feuerstein I, et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807–814
  110. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112:572–577
  111. Yoon HC, Emerick AM, Hill JA, et al. Calcium begets calcium: Progression of coronary artery calcification in asymptomatic subjects. Radiology. 2002;224:236–241
  112. Budoff MJ, Lane KL, Bakhsheshi H, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol. 2000;86:8–11
  113. Maher JE, Bielak LF, Raz JA, et al. Progression of coronary artery calcification: a pilot study. Mayo Clin Proc. 1999;74:347–355
  114. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol. 2004;24:1272–1277
  115. Raggi P, Cooil B, Ratti C, et al. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension. 2005;46:238–243
  116. Raggi P, Cooil B, Shaw LJ, et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol. 2003;92:827–829
  117. Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation. 2005;112:563–571
  118. Schmermund A, Achenbach S, Budde T, et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation. 2006;113:427–437
  119. Schoenhagen P, Halliburton SS, Stillman AE, et al. Noninvasive imaging of coronary arteries: current and future role of multi-detector row CT. Radiology. 2004;232:7–17
  120. Schoepf UJ, Becker CR, Ohnesorge BM, et al. Of coronary artery disease. Radiology. 2004;232:18–37
  121. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol. 1990;15:459–474
  122. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703–1708
  123. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?. N Engl J Med. 1984;310:819–824
  124. Hamon M, Biondi-Zoccai GG, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a metal-analysis. J Am Coll Cardiol. 2006;48:1896–1910
  125. Garcia MJ, Lessick J, Hoffmann MH. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006;296:403–411
  126. Hoffmann U, Moselewski F, Cury RC, et al. Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease: patient-versus segment-based analysis. Circulation. 2004;110:2638–2643
  127. Raff GL, Gallagher MJ, O'Neill WW, et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol. 2005;46:552–557
  128. Stein PD, Yaekoub AY, Matta F, et al. 64-Slice CT for diagnosis of coronary artery disease: a systematic review. Am J Med. 2008;121:715–725
  129. Dewey M, Dubel HP, Schink T, et al. Head-to-head comparison of multislice computed tomography and exercise electrocardiography for diagnosis of coronary artery disease. Eur Heart J. 2006;(Epub ahead of print)
  130. Mollet NR, Cademartiri F, Van Mieghem C, et al. Adjunctive value of CT coronary angiography in the diagnostic work-up of patients with typical angina pectoris. Eur Heart J. 2007;28:1872–1878
  131. Sankatsing RR, de Groot E, Jukema JW, et al. Surrogate markers for atherosclerotic disease. Curr Opin Lipidol. 2005;16:434–441
  132. Ghostine S, Caussin C, Habis M, et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J. 2008;29(17):2133–2140
  133. Scheffel H, Leschka S, Plass A, et al. Accuracy of 64-slice computed tomography for the preoperative detection of coronary artery disease in patients with chronic aortic regurgitation. Am J Cardiol. 2007;100:701–706
  134. Ghostine S, Caussin C, Daoud B, et al. Non-invasive detection of coronary artery disease in patients with left bundle branch block using 64-slice computed tomography. J Am Coll Cardiol. 2006;48:1929–1934
  135. Stillman AE, Oudkerk M, Ackerman M, et al. Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology. Int J Cardiovasc Imaging. 2007;23:415–427
  136. Goldstein JA, Gallagher MJ, O'Neill WW, et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol. 2007;49:863–871
  137. Vrachliotis TG, Bis KG, Haidary A, et al. Atypical chest pain: Coronary, aortic, and pulmonary vasculature enhancement at biphasic single-injection 64-section CT angiography. Radiology. 2007;243:368–376
  138. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863–1869
  139. Sommer T, Hofer U, Hackenbroch M, et al. Submillimeter 3D coronary MR angiography with real-time navigator correction in 107 patients with suspected coronary artery disease. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2002;174:459–466
  140. Schuijf JD, Bax JJ, Shaw LJ, et al. Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J. 2006;151:404–411
  141. Kefer J, Coche E, Legros G, et al. Head-to-head comparison of three-dimensional navigator-gated magnetic resonance imaging and 16-slice computed tomography to detect coronary artery stenosis in patients. J Am Coll Cardiol. 2005;46:92–100
  142. Dewey M, Teige F, Schnapauff D, et al. Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann Intern Med. 2006;145:407–415
  143. Dewey M, Teige F, Schnapauff D, et al. Combination of free-breathing and breathhold steady-state free precession magnetic resonance angiography for detection of coronary artery stenoses. J Magn Reson Imaging. 2006;23:674–681
  144. Nagel E, Pettigrew RI. Myocardial ischemia in conditions other than atheromatous coronary artery disease. In:  Anagnostopoulos CD,  Bax JJ,  Nihouannopoulos P, et al. editor. Noninvasive Imaging of Myocardial Ischemia. London: Springer Verlag; 2006;p. 227–286
  145. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee to Update the 1999 guidelines for coronary artery bypass graft surgery). Circulation. 2004;110:1168–1176
  146. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC. /AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 guidelines for percutaneous coronary intervention). Circulation. 2006;113:156–175
  147. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J. 2004;25:1657–1665
  148. Lee DC, Simonetti OP, Harris KR, et al. Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation. 2004;110:58–65
  149. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379–1383
  150. Ibrahim T, Nekolla SG, Schreiber K, et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol. 2002;39:864–870
  151. Plein S, Radjenovic A, Ridgway JP, et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology. 2005;235:423–430
  152. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001;103:2230–2235
  153. Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47:1427–1432
  154. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests (Adenosine stress perfusion and dobutamine stress wall motion imaging). Circulation. 2007;115:e457–e459
  155. Georgiou D, Wolfkiel C, Brundage BH. Ultrafast computed tomography for the physiological evaluation of myocardial perfusion. Am J Card Imaging. 1994;8:151–158
  156. George RT, Silva C, Cordeiro MA, et al. Multidetector computed tomography myocardial perfusion imaging during adenosine stress. J Am Coll Cardiol. 2006;48:153–160
  157. Mahnken AH, Gunther RW, Krombach G. Contrast-enhanced MR and MSCT for the assessment of myocardial viability. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2006;178:771–780
  158. Nikolaou K, Sanz J, Poon M, et al. Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol. 2005;15:864–871
  159. Nieman K, Cury RC, Ferencik M, et al. Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol. 2006;98:303–308
  160. Lardo AC, Cordeiro MA, Silva C, et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006;113:394–404
  161. Gerber BL, Belge B, Legros GJ, et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006;113:823–833
  162. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999;99:763–770
  163. Wahl A, Paetsch I, Roethemeyer S, et al. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology. 2004;233:210–216
  164. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999;100:1697–1702
  165. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006;27:1459–1464
  166. Mandapaka S, Hundley WG. Dobutamine cardiovascular magnetic resonance: a review. J Magn Reson Imaging. 2006;24:499–512
  167. van Rugge FP, van der Wall EE, de Roos A, et al. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol. 1993;22:431–439
  168. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109:2172–2174
  169. Hundley WG, Morgan TM, Neagle CM, et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002;106:2328–2333
  170. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671
  171. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circul Res. 2001;89:305–316
  172. Achenbach S, Ropers D, Hoffmann U, et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol. 2004;43:842–847
  173. Schoenhagen P, Tuzcu EM, Stillman AE, et al. Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: Comparison of 16-slice computed tomography and intravascular ultrasound. Coron Artery Dis. 2003;14:459–462
  174. Hausleiter J, Meyer T, Hadamitzky M, et al. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol. 2006;48:312–318
  175. Hoffmann U, Moselewski F, Nieman K, et al. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol. 2006;47:1655–1662
  176. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319–326
  177. Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol. 2001;37:1430–1435
  178. Achenbach S, Moselewski F, Ropers D, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation. 2004;109:14–17
  179. Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol. 2004;43:1241–1247
  180. Halliburton SS, Schoenhagen P, Nair A, et al. Contrast enhancement of coronary atherosclerotic plaque: a high-resolution, multidetector-row computed tomography study of pressure-perfused, human ex vivo coronary arteries. Coron Artery Dis. 2006;17:553–560
  181. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol. 2006;47:672–677
  182. Pundziute G, Schuijf JD, Jukema JW, et al. Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;49:62–70
  183. Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161–1170
  184. Ostrom MP, Gopal A, Ahmadi N, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2009;(in press)
  185. Kerwin WS, O'Brien KD, Ferguson MS, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology. 2006;241:459–468
  186. Kim WY, Stuber M, Bornert P, et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation. 2002;106:296–299
  187. Kim WY, Astrup AS, Stuber M, et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in Type 1 diabetes with and without diabetic nephropathy. Circulation. 2007;115:228–235
  188. Maintz D, Ozgun M, Hoffmeier A, et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J. 2006;27:1732–1736
  189. Yeon SB, Sabir A, Clouse M, et al. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol. 2007;50:441–447
  190. Budoff MJ, Cohen MC, Garcia MJ, et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation. 2005;112:598–617
  191. Woodard PK, Bluemke DA, Cascade PN, et al. ACR practice guideline for the performance and interpretation of cardiac magnetic resonance imaging (MRI). J Am Coll Radiol. 2006;3:665–676
  192. Budoff MJ, Achenbach S, Berman DS, et al. Task force 13: training in advanced cardiovascular imaging (computed tomography) endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2008;51:409–414
  193. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on cardiovascular radiology and intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–1791
  194. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation. 2008;118:586–606
  195. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940–1965
  196. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475–1497
  197. Study of perfusion and anatomy's role in CAD. http://clinicaltrials.gov/ct/show/NCT00321399?order=1Accessed on Feb 5, 2009

 The use of gadolinium chelates for cardiovascular magnetic resonance imaging as discussed in this article is off-label and not FDA-approved.

 Eike Nagel is a consultant to Berlex/Schering and Bracco.

 Jörg Barkhausen receives honorariums from Schering and Siemens, receives research grants from Schering and Guerbet, is a consultant for Schering and Guerbet, and is on the advisory board of Guerbet.

 Paul Schoenhagen receives an honorarium from Takeda Pharmaceuticals (paid directly to charity and higher education).

 Thomas C. Gerber is an associate editor of Mayo Clinic Proceedings.

 The authors have no other conflicts of interest to disclose.

 This work was supported in part by NIH Grant 1R01EB007986-02 (“Noninvasive Localization of Vulnerable Plaques”) awarded to Dr. Birgit Kantor.

PII: S0146-2806(08)00184-9

doi: 10.1016/j.cpcardiol.2008.12.002

Current Problems in Cardiology
Volume 34, Issue 4 , Pages 145-217 , April 2009

Article Tools

* Image Usage & Resolution